Technical Analysis for ETON - Eton Pharmaceutcials, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Expansion Breakdown | Bearish Swing Setup | 0.00% | |
Volume Surge | Other | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Fell Below 20 DMA | Bearish | -9.61% | |
Fell Below 200 DMA | Bearish | -9.61% | |
MACD Bearish Signal Line Cross | Bearish | -9.61% | |
180 Bearish Setup | Bearish Swing Setup | -9.61% | |
Expansion Breakdown | Bearish Swing Setup | -9.61% | |
Earnings Movers | Other | -9.61% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 14 hours ago |
Down 10% | about 14 hours ago |
Down 2 ATRs | about 14 hours ago |
2x Volume Pace | about 20 hours ago |
1.5x Volume Pace | about 20 hours ago |
Get a Trading Assistant
- Earnings date: 03/14/2024
Eton Pharmaceutcials, Inc. Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical product using the U.S. Food and Drug Administration's 505(b)(2) regulatory pathway. It primarily focuses on liquid products, including injectable, oral liquid, and ophthalmic products. The company is developing DS-300, an injectable nutrition product candidate; EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-103, an oral liquid product candidate; DS-100, an injectable product candidate for use in pain management; DS-200, an injectable parenteral nutrition product candidate; ET-101, an oral liquid product for use in seizure control; ET-102, an oral liquid product for use as a muscle relaxant; and CT-100, a synthetic corticotropin therapeutic candidate that mimics the amino acid chain of H.P. Acthar Gel. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Acid Pain Pharmaceutical Products Ophthalmic Pain Management Seizure Allergic Conjunctivitis Mimics Ophthalmic Product Ophthalmic Products Liquid Products Parenteral Nutrition
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.81 |
52 Week Low | 2.42 |
Average Volume | 70,801 |
200-Day Moving Average | 4.06 |
50-Day Moving Average | 4.45 |
20-Day Moving Average | 4.38 |
10-Day Moving Average | 4.29 |
Average True Range | 0.23 |
RSI (14) | 23.66 |
ADX | 24.26 |
+DI | 9.61 |
-DI | 43.41 |
Chandelier Exit (Long, 3 ATRs) | 3.93 |
Chandelier Exit (Short, 3 ATRs) | 4.09 |
Upper Bollinger Bands | 4.87 |
Lower Bollinger Band | 3.88 |
Percent B (%b) | -0.4 |
BandWidth | 22.76 |
MACD Line | -0.12 |
MACD Signal Line | -0.03 |
MACD Histogram | -0.0837 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.10 | ||||
Resistance 3 (R3) | 4.14 | 3.97 | 3.99 | ||
Resistance 2 (R2) | 3.97 | 3.82 | 3.95 | 3.96 | |
Resistance 1 (R1) | 3.73 | 3.72 | 3.65 | 3.69 | 3.92 |
Pivot Point | 3.56 | 3.56 | 3.52 | 3.54 | 3.56 |
Support 1 (S1) | 3.32 | 3.41 | 3.24 | 3.28 | 3.04 |
Support 2 (S2) | 3.15 | 3.31 | 3.13 | 3.00 | |
Support 3 (S3) | 2.91 | 3.15 | 2.97 | ||
Support 4 (S4) | 2.87 |